APP and Alzheimer disease: In an AD-mouse model (5xFAD) that bear multiple amyloid β precursor gene (APP) and PSEN1 variants, reducing Ca2+ release from the ER via replacing the WT RyR2 with a mutated one prevented the hyperactivity of pyramidal neurons [14].